Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Lol. Sth like that yes.
Meanwhile I'm trying to focus on scanning... :)
Can't argue with that. Always looking for the right set-up. :)
Hope people took advantage of that post, they had 45 mins to prepare mentally :) TBH, they don't come that much more gift wrapped than this one.
I had feeling this would do a run, but not this hard: what an EOD, damn. What's the rush, lol.
As usual, no I didn't... Had my eyes elsewhere.
Just to be clear, not passing judgment, I'm impressed you can manage that many, I usually only do one stock at a time. Then again, my time frame is quite myopic lol.
As you say, on good days as we've had you got a lot of boats being pushed on the high waves.
Lol, I see. Especially since you add options to the mix, as if it weren't fun enough ;)
I see, the work's 'evenly' split. :)
Impressive list, congrats to anyone who manages 10+.
You're nuts cj :) How d'you follow all those??
Well done, could end break-even but why take the chance. Games rarely come in 1 wave.
Well, get away may be exaggerating a bit, it's been crawling up ;)
Nasty games, welcome to pinkyland. :)
Been watching this one slide, ugly. Keep waiting for a real technical bounce. You think we nearing bottom?
One of iHub's biggest stocks, I bet there's plenty of tears right now.
VM ticker is VUME
Don't get me drooling :) Is looking nice, though.
Stuck between the 20 & 100MA. Fun definitely not over yet :)
Nice DB. Bios been getting plenty of love again.
It did close over the 50MA, I'm thinking 0.77 then the 100MA?
Like ISIS, it seems to be heading higher in PM. Could be another strong day, plenty of room on the chart.
There's a boatload of PM movers, I'm having hard time keeping up.
ROSG: +18% in PM
Rosetta Genomics Reports Study Comparing microRNA Profiles of Cancer of Unknown Primary and Metastases of Known Primary Tumors Published in Clinical Experimental Metastasis
http://finance.yahoo.com/news/rosetta-genomics-reports-study-comparing-133000638.html
Lol, you must've been checking some other potentials. These doublers are always something to be envious of.
NUVA: +16% in PM
Good preliminary results:
http://finance.yahoo.com/news/nuvasive-announces-preliminary-unaudited-full-133000478.html
200MA may be magnet for more or a wall.
Richmont Mines receives mining permit for Monique Gold Project
Co announced that it has received the required mining permits for its 100%-owned Monique Gold Project located in Val-d'Or, Quebec. The Corporation will begin overburden removal shortly, with a view to extracting a 5,000 tonne bulk sample to be processed at its 100%-owned Camflo Mill in 2013. If the results from the bulk sampling phase are favourable, open pit mining and milling would proceed over the following 2 year period, the approval for which is inclusive in the permit. The open pit phase could potentially be followed by an underground phase, for which a permit amendment would need to be obtained.
Cell Therapeutics begins enrollment in Phase 3 trial of Pacritinib
Cell Therapeutics announced that the company has initiated clinical trial sites and began enrolling patients in a Phase 3 clinical trial, known as PERSIST-1 or PAC325, for pacritinib, CTI's investigational JAK2 inhibitor, which is being evaluated for the treatment of patients with myelofibrosis. The randomized trial is expected to enroll 270 patients and will evaluate the safety and efficacy of pacritinib compared to best available therapy, excluding JAK inhibitors, in patients with myelofibrosis. Pacritinib is a selective oral JAK2 inhibitor that demonstrated meaningful clinical benefits and good tolerability in myelofibrosis patients in Phase 2 clinical trials, without apparent drug-related thrombocytopenia or anemia. Myelofibrosis patients will be enrolled in the PERSIST-1 trial without exclusion for low platelet counts.
Lol, yes, that's my fav line, investors finally realised the stock was undervalued. At least with ROSG I had some idea what was happening :)
Thx for that $SF. Makes sense.
The wonders of the world's biggest casino. :)